Who We Are
Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.
Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.
Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.
Key Issues
Causes We Care About, and So Should You!
HIV
Promote necessary funding, programs, and policies to end the HIV epidemic in the United States
HEPATITIS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States
HEALTHCARE ACCESS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States
Facebook posts by @HIV+Hep
The HIV and Hepatitis Policy Institute submitted testimony on the proposed Rhode Island Drug Cost Review Commission (H8220) urging lawmakers to focus instead on issues that can directly lower #outofpocket costs for #patients like #PBM reform & ensuring #AllCopaysCount: bit.ly/3ybP38q
The HIV and Hepatitis Policy Institute’s Carl Schmid had the pleasure being the dinner speaker of the LatinxNetwork’s #hispanichealthsummit on federal health policy & the impact of #HIV, STIs, #hepatitis, & substance abuse on the Hispanic/Latinx community: hispanicnet.org/
We thank the 101 Congressional members who signed a bipartisan letter urging House Appropriations Democrats, House Committee on Appropriations to fully fund domestic #HIV progs, led by Congressman Bill Pascrell, Jr. Congresswoman Barbara Lee Maxine Waters Rep. Jenniffer González-Colón Jerry Nadler Congressman Robert Garcia: bit.ly/3Qqif1A
#Patients are being faced with high #costsharing, excessive utilization management techniques, such as prior authorization, #Rx exclusions & now even AI tools that decide what drugs they can receive. We thank the U.S. Department of Health and Human Services for strengthening ACA non-discrimination rules:
bit.ly
“We applaud the Biden administration’s strengthening of the nondiscrimination regulation in order to ensure that patients, particularly those who rely on prescription drugs, are better protected a...
www.propublica.org
Cigna tracks every minute that its staff doctors spend deciding whether to pay for health care. Dr. Debby Day said her bosses cared more about being fast than being right: “Deny, deny, deny. That’...